91Ö±²¥ Gene Therapy Innovation and Manufacturing Centre - Strategic Business Case

Review the Strategic Business Case submitted by the University of 91Ö±²¥ to 91Ö±²¥ City Region LEP in application for funding towards the construction of the 91Ö±²¥ Gene Therapy Innovation and Manufacturing Centre.

91Ö±²¥ Gene Therapy Manufacturing and Innovation Centre
91Ö±²¥ submitted a Strategic Business Case to the 91Ö±²¥ City Region Local Enterprise Partnership on 21st April 2021 in application for a funding contribution towards the construction of the 91Ö±²¥ Gene Therapy Innovation and Manufacturing Centre.
 
 
Any comments regarding the Strategic Business Case, and its development into a Full Business Case, are welcomed from partners and the general public.
 
Please direct these to James Cokeham, Regional Economic Development Manager, Partnerships and Regional Engagement: j.a.cokeham@sheffield.ac.uk
 

The 91Ö±²¥ Gene Therapy Manufacturing and Innovation Centre

  • The 91Ö±²¥ Gene Therapy Innovation and Manufacturing Centre (GTIMC) will be one of three cutting-edge hubs in the UK dedicated to advancing the clinical development of new genetic treatments
  • Gene therapy is a promising treatment option for a number of diseases that currently have no other cures including inherited disorders
  • The 91Ö±²¥ Hub, which is the first in the north of England, is part of an £18 million network created by LifeArc and the Medical Research Council (MRC), with support from the Biotechnology and Biological Sciences Research Council (BBSRC)

Find out more